iCAD's VividLook



September 16, 2009 - iCAD Inc. will host a series of educational events designed for radiologists, urologists, oncologists, radiation oncologists, surgeons, technologists and other referring physicians who diagnose and treat patients with prostate cancer.

Two webinars, entitled “Prostate MRI – A Paradigm Shift in Prostate Cancer Diagnosis and Management” will focus on how MRI combined with an advanced quantitative image analysis software solution, (iCAD’s VividLook), supports improved prostate cancer management. The course will include clinical case reviews that will demonstrate prostate cancer detection in patients with previously negative prostate biopsy and rising PSA, as well as the use of dynamic contrast enhanced (DCE) MRI and Computer-Aided Detection (CAD) to monitor prostate cancer response to radiation therapy.

They will be held on:
· October 15, 2009, at noon ET, with Dr. François Cornud, diagnostic and interventional radiologist at the Centre d’Imagerie Tourville
· November 10, 2009, at 3 pm ET, with Dr. Russell Low, medical director at Sharp and Children’s MRI Center and Assistant Clinical Professor at the University of California San Diego School of Medicine.

In addition, a non-RSNA satellite symposium will be held on Tuesday, December 1, 2009 at 7am CT at the Hyatt Regency in Chicago, room CC24BC. The session, “How quantitative image analysis CAD and MRI play an integral role in prostate cancer programs including pre-biopsy guidance, treatment planning, active surveillance and therapy response monitoring,” will include presentations by clinical experts, Dr. Cornud and Dr. Low. Specific focus areas include how DCE MRI in conjunction with other MRI imaging techniques can improve the sensitivity and specificity of prostate cancer localization and detection as compared to current imaging practices. Specific case examples will be shared, including how DCE MRI and CAD support improved treatment planning for patients undergoing Cyberknife therapy.

For more information: www.icadmed.com


Related Content

News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Clinical Trials

June 27, 2024 — Prenuvo, which makes whole-body MRI screening for early cancer detection and other diseases, has ...

Time June 27, 2024
arrow
News | Pediatric Imaging

June 25, 2024 — Rady Children’s Hospital-San Diego, one of the nation’s top pediatric health care systems, today ...

Time June 25, 2024
arrow
News | Artificial Intelligence

June 17, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care ...

Time June 17, 2024
arrow
Subscribe Now